BRCA1 and breast angiosarcoma: To extend our studies of BA treatments to an additional HGSC model, we acquired BR5-Luc cells derived from surface ovarian epithelial cells of transgenic Trp53−/−:Brca1−/−:Tg−Myc mice (FVB strain) [37].